ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2021
Variation in Best Practice Measures in Patients With Severe Hospital-Acquired Acute Kidney Injury: A Multicenter Study.
Abstract readLetterMulticenter Study
In one paragraph
Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Early Nephrology Consultation and Acute Kidney Injury in Hospitalized Patients: A Randomized Clinical Trial.JAMA network open · 2026Trial
- A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes.Nature communications · 2023Trial
- Development and Validation of Machine Learning Models to Identify Emergency Department Patients at Increased Risk of New or Progressive Acute Kidney Injury.Journal of the American College of Emergency Physicians open · 2026Article
- Multicenter Development and Validation of a Multimodal Deep Learning Model to Predict Moderate to Severe AKI.Clinical journal of the American Society of Nephrology : CJASN · 2025Article
- Triglyceride-glucose-body mass index predicts early-onset acute kidney injury in critically ill patients: a retrospective analysis using the MIMIC-IV database.Frontiers in nutrition · 2025Article
- Assessing the role of Chemokine (C-C motif) ligand 14 in AKI: a European consensus meeting.Renal failure · 2024Article
- 10 tips on how to use dynamic risk assessment and alerts for AKI.Clinical kidney journal · 2024Review
- Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14).ClinicoEconomics and outcomes research : CEOR · 2024Article
- Biomarker Enrichment in Sepsis-Associated Acute Kidney Injury: Finding High-Risk Patients in the Intensive Care Unit.American journal of nephrology · 2024Review
- Article
- Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury.Critical care explorations · 2023Article
- Outcomes, Healthcare Resource Utilization, and Costs of Overall, Community-Acquired, and Hospital-Acquired Acute Kidney Injury in COVID-19 Patients.Journal of health economics and outcomes research · 2023Article
- Performance of a Standardized Clinical Assay for Urinary C-C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury.Kidney360 · 2022Article
- Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy.Journal for immunotherapy of cancer · 2022Observational
- COVID-19 Survival and its impact on chronic kidney disease.Translational research : the journal of laboratory and clinical medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Dennis G MoledinaSection of Nephrology and Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Olivia BelliveauSection of Nephrology and Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Yu YamamotoSection of Nephrology and Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Tanima AroraSection of Nephrology and Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Kyle A CareySection of Nephrology, Department of Internal Medicine, University of Chicago School of Medicine, Chicago, IL.
Matthew ChurpekSection of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Wisconsin, Madison, WI.
Melissa MartinSection of Nephrology and Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Caitlin M PartridgeYale Center for Clinical Investigation, Yale School of Medicine, New Haven, CT.
Sherry G MansourSection of Nephrology and Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Chirag R ParikhDivision of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, MD.
Jay L KoynerSection of Nephrology, Department of Internal Medicine, University of Chicago School of Medicine, Chicago, IL.
F Perry WilsonSection of Nephrology and Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, CT. Electronic address: francis.p.wilson@yale.edu.
Funding
Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S. · 2008 to 2022
$16.8MNovel Biomarkers in Cardiac Surgery to Detect Acute Kidney InjuryR01HL085757 · NHLBI · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2007 to 2019
$10.3MProgression of Acute Kidney Injury to Chronic Kidney DiseaseU01DK082185 · NIDDK · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2008 to 2017
$5.1MOptimizing Electronic Alerts for Acute Kidney InjuryR01DK113191 · NIDDK · YALE UNIVERSITY · PI WILSON, FRANCIS PERRY · 2018 to 2022
$3.1MPersonalized Recommendations for Acute Kidney Injury (AKI) Care Using a Kidney Action Team: A Randomized TrialR01HS027626 · AHRQ · YALE UNIVERSITY · PI WILSON, FRANCIS PERRY · 2021 to 2025
$1.9MIdentification of Non-Invasive Biomarkers and Indices for Diagnosis of Drug-Induced Acute Interstitial NephritisK23DK117065 · NIDDK · YALE UNIVERSITY · PI MOLEDINA, DENNIS G. · 2018 to 2022
$920kAn Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury: A Randomized Trial of an Early Standardized, Personalized Nephrology InterventionR21DK113420 · NIDDK · UNIVERSITY OF CHICAGO · PI KOYNER, JAY L · 2018 to 2019
$446kAHRQ HHS R01 HS027626NHLBI NIH HHS R01 HL085757NIDDK NIH HHS K23 DK117065NIDDK NIH HHS P30 DK079310NIDDK NIH HHS R01 DK113191NIDDK NIH HHS R21 DK113420NIDDK NIH HHS U01 DK082185
Abstract
PubMed holds no abstract for this paper.
Indexed as
HospitalizationSeverity of Illness IndexAcute Kidney InjuryAgedAged, 80 and overAnti-Inflammatory Agents, Non-SteroidalBenchmarkingFemaleHumansMaleMiddle AgedAnti-Inflammatory Agents, Non-Steroidal
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.